Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
| Descriptor ID |
D009364
|
| MeSH Number(s) |
C04.697.655 C23.550.727.655
|
| Concept/Terms |
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in this website by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 4 | 6 |
| 1997 | 0 | 6 | 6 |
| 1998 | 1 | 7 | 8 |
| 1999 | 2 | 0 | 2 |
| 2000 | 5 | 7 | 12 |
| 2001 | 1 | 15 | 16 |
| 2002 | 5 | 4 | 9 |
| 2003 | 5 | 8 | 13 |
| 2004 | 6 | 12 | 18 |
| 2005 | 6 | 10 | 16 |
| 2006 | 10 | 13 | 23 |
| 2007 | 12 | 6 | 18 |
| 2008 | 12 | 5 | 17 |
| 2009 | 9 | 15 | 24 |
| 2010 | 18 | 22 | 40 |
| 2011 | 9 | 19 | 28 |
| 2012 | 11 | 5 | 16 |
| 2013 | 19 | 17 | 36 |
| 2014 | 21 | 13 | 34 |
| 2015 | 23 | 17 | 40 |
| 2016 | 19 | 14 | 33 |
| 2017 | 24 | 19 | 43 |
| 2018 | 21 | 25 | 46 |
| 2019 | 20 | 21 | 41 |
| 2020 | 24 | 27 | 51 |
| 2021 | 12 | 43 | 55 |
| 2022 | 6 | 51 | 57 |
| 2023 | 2 | 45 | 47 |
| 2024 | 20 | 24 | 44 |
| 2025 | 35 | 12 | 47 |
| 2026 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma. Blood. 2026 04 30; 147(18):2041-2052.
-
Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors. Pediatr Blood Cancer. 2026 May; 73(5):e70199.
-
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study. Pediatr Blood Cancer. 2026 May; 73(5):e70195.
-
PD-L1 positivity predicts a unique hyperaggressive tumor group within MenG C meningiomas. JNCI Cancer Spectr. 2026 Mar 03; 10(2).
-
Children and Young People With First Relapse or Progression of Upfront Metastatic Rhabdomyosarcoma: An Analysis of Clinical Features and Outcomes From the INternational Soft Tissue saRcoma ConsorTium (INSTRuCT). Cancer Med. 2026 Mar; 15(3):e71524.
-
A Novel Risk Stratification Tool for Sinonasal Inverted Papilloma Recurrence: Multi-Institutional Nomogram Incorporating Dysplasia Severity. Int Forum Allergy Rhinol. 2026 Mar; 16(3):287-291.
-
17?-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark. Breast Cancer Res. 2025 Dec 30; 28(1):28.
-
Cutaneous Melanoma: A Review. JAMA. 2025 Dec 16; 334(23):2113-2125.
-
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma. Clin Cancer Res. 2025 Dec 15; 31(24):5225-5236.
-
Sinonasal Inverted Papilloma and Clinical Significance of Dysplasia: A Multi-Institutional Study. Laryngoscope. 2026 Apr; 136(4):1656-1664.